Praxbind Side Effects

Generic name: idarucizumab

Medically reviewed by Drugs.com. Last updated on Mar 15, 2025.

Note: This document provides detailed information about Praxbind.

Applies to idarucizumab: intravenous solution Side Effects associated with idarucizumab. Some dosage forms listed on this page may not apply specifically to the brand name Praxbind.

Applies to idarucizumab: intravenous solution.

Precautions

Your doctor will check your progress closely while you are receiving this medicine. This will allow your doctor to see if the medicine is working properly. Blood tests will be needed to check for unwanted effects.

This medicine may increase your risk of blood clots. Tell your doctor if you have the following symptoms: pain in the chest, groin, or legs, especially the calves, difficulty with breathing, severe, sudden headache, slurred speech, sudden, unexplained shortness of breath, sudden loss of coordination, sudden, severe weakness or numbness in the arm or leg, or vision changes.

This medicine may cause serious allergic reactions, including anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Call your doctor right away if you have a rash, itching, trouble breathing, trouble swallowing, or any swelling of your hands, face, or mouth while you are receiving this medicine.

This medicine may cause serious side effects in patients with hereditary fructose intolerance. Tell your doctor right away if you have increased hunger, cold sweats, blurred vision, fast heartbeat, shakiness, trembling, stomach pain, dark urine or light colored stools, unusual tiredness or weakness, or yellow eyes or skin.

Serious side effects of Praxbind

Along with its needed effects, idarucizumab (the active ingredient contained in Praxbind) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking idarucizumab:

For healthcare professionals

Applies to idarucizumab: intravenous solution.

General adverse events

The most common adverse reactions were hypokalemia, delirium, constipation, pyrexia, pneumonia, and headache.^[Ref]

Cardiovascular

• Common (1% to 10%): Thrombotic events^[Ref]

Metabolic

• Common (1% to 10%): Hypokalemia^[Ref]

Psychiatric

• Common (1% to 10%): Delirium^[Ref]

Gastrointestinal

• Common (1% to 10%): Constipation, nausea^[Ref]

Other

• Common (1% to 10%): Pyrexia^[Ref]

Respiratory

• Common (1% to 10%): Pneumonia
• Frequency not reported: Bronchospasm, hyperventilation^[Ref]

Nervous system

• Common (1% to 10%): Headache^[Ref]

Dermatologic

• Frequency not reported: Rash, pruritus^[Ref]

Immunologic

• Frequency not reported: Hypersensitivity reactions^[Ref]

See also:

Further information

Praxbind side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer